Invasive infection caused by Candida species is a condition associated with medical
progress. It is a common health care–associated infection (HAI), and is widely recognized as …

The epidemiology of invasive candidiasis has evolved in recent years, warranting a review
of the changes and the implications for current and future diagnosis and treatment. The …

It is important to realize that guidelines cannot always account for individual variation among
patients. They are not intended to supplant physician judgment with respect to particular …

Within the limited antifungal armamentarium, the azole antifungals are the most frequent
class used to treat Candida infections. Azole antifungals such as fluconazole are often …

Patients with suppressed immunity are at the highest risk for hospital-acquired infections.
Among these, invasive candidiasis is the most prevalent systemic fungal nosocomial …

The epidemiology of Candida infections has changed in recent years. Although Candida
albicans is still the main cause of invasive candidiasis in most clinical settings, a substantial …

The Candida genus comprises opportunistic fungi that can become pathogenic when the
immune system of the host fails. Candida albicans is the most important and prevalent …

Invasive infection due to Candida species is a condition associated with medical progress. It
is a common health care–associated infection and is widely recognized as a major cause of …

The echinocandin class of antifungal agents is considered to be the first-line treatment of
bloodstream infections (BSI) due to Candida glabrata. Recent reports of BSI due to strains of …

Epidemiology of invasive candidiasis : Current Opinion in Critical Care Epidemiology of invasive
candidiasis : Current Opinion in Critical Care Log in or Register Subscribe to journalSubscribe …